Stay updated with breaking news from Subcutaneous Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable formulation of risperidone microspheres Additional UZEDY...
Regeneron Pharmaceuticals, Inc. Share Price Target '$1,016.86', now 8.4% Upside Potential
Regeneron Pharmaceuticals, Inc. - Consensus 'buy' rating and 9.1% Upside Potential
Teva will share 16 data presentations across its neuroscience portfolio including AUSTEDO, once-daily AUSTEDO XR, UZEDY, TV-44749 and AJOVY® injection Presentation highlights include data for...
Teva will share 16 data presentations across its neuroscience portfolio including AUSTEDO, once-daily AUSTEDO XR, UZEDY, TV-44749 (olanzapine) and AJOVY® (fremanezumab) injectionPresentation highlights include data for AUSTEDO in the tardive dyskinesia (TD) START study on real-world effectiveness and adherence when...